Larry -
I quite agree as regards the Company's "condition" -- indeed, I think it is in the strongest position it has ever been in (better, even than when the stock was at an artificially high 8).
In broad brush strokes:
The Biomar buyout pulled us back from the brink of bankruptcy
The Scherer contracts make the Company viable - indeed, profitable
The results of the collaboration with SRI -- recall, they're working on 10 different extracts -- will make the stock soar. One product that can go the FDA route will launch us; a second . . ..
(Just one stockholder's opinion.)
Hadn't thought of the warrants angle that you mention; sounds as plausible as any explanation I've heard. Two noteworthy facts: 1. The volume on this downward slide has been quite low. 2. Anyone buying a warrant today, at $.15+, has to be thinking that the stock will be above $1.90 (the cost of the warrant + the strike price) by the end of the year (or exceed the subsequent steps in strike price). (Alternatively, the buyers could think that the price of the warrants will go up, and be shooting for a "double," etc. But to do that is to believe that others -- one's potential buyers -- will believe that the price of the stock will exceed the strike price + the warrant price.) In any event -- why did the warrant price go up today, on a volume of 28,000+, while the price of the shares continued to slide?
Finally: Is there any way to tell whether the recent selling of shares, usually at the bid, is actual retail selling, or just Market Maker meddling?
Thoughts of others??
Jonathan |
